Literature DB >> 29203594

Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties.

Anissa I Vines1, William R Carpenter2, Ronald C Chen3, Michele W Cherry4, Debra G Long5, Keith D Amos6, Paul A Godley7.   

Abstract

BACKGROUND A 2007 national report identified North Carolina's Edgecombe County as having among the highest breast cancer incidence and mortality rates nationally, motivating the initiation of a task force and other local efforts to address the problem. The goal of this study is to examine county breast cancer characteristics before and after the report, including whether geographic variation may mask racial disparities in this majority African American community.METHOD With guidance from community partners, breast cancer cases from 2000 to 2012 in Edgecombe, Nash, and Orange Counties (N = 2,641) were obtained from the North Carolina Central Cancer Registry. Bivariate and trend analyses of tumor and treatment characteristics were examined by county and race.RESULTS Women in Edgecombe and Nash Counties were diagnosed with more advanced stage, higher grade tumors. African Americans in Edgecombe and Nash Counties were diagnosed with advanced disease more often than African Americans in Orange County. Average time-to-treatment was well within guideline recommendations. Incidence and mortality rates appear to have declined, with variation in measures of racial differences over time.LIMITATIONS Changes in coding standards across the observation period required reliance on coarse measures that may partially mute useful findings.CONCLUSIONS Racial disparities remain a concern in North Carolina; however, they appear to be less profound than in the 2007 national report. The portentous statistics in the report represent an all-time high, after which some, but not all, measures reflect positive change amidst ongoing local efforts to improve breast cancer knowledge and care. ©2017 by the North Carolina Institute of Medicine and The Duke Endowment. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29203594      PMCID: PMC5806525          DOI: 10.18043/ncm.78.6.357

Source DB:  PubMed          Journal:  N C Med J        ISSN: 0029-2559


  22 in total

1.  A community-academic partnership to plan and implement an evidence-based lay health advisor program for promoting breast cancer screening.

Authors:  Randall Teal; Alexis A Moore; Debra G Long; Anissa I Vines; Jennifer Leeman
Journal:  J Health Care Poor Underserved       Date:  2012-05

Review 2.  Chemotherapeutic Strategies for advanced breast cancer.

Authors:  Susanne Briest; Vered Stearns
Journal:  Oncology (Williston Park)       Date:  2007-10       Impact factor: 2.990

Review 3.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

Authors:  M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

Review 4.  NIH consensus conference. Treatment of early-stage breast cancer.

Authors: 
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

5.  Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.

Authors:  Judith Swan; Nancy Breen; Ralph J Coates; Barbara K Rimer; Nancy C Lee
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

6.  Lifestyle factors and survival in women with breast cancer.

Authors:  Lawrence H Kushi; Marilyn L Kwan; Marion M Lee; Christine B Ambrosone
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

7.  Validity of cancer registry data for measuring the quality of breast cancer care.

Authors:  Jennifer L Malin; Katherine L Kahn; John Adams; Lorna Kwan; Marianne Laouri; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2002-06-05       Impact factor: 13.506

Review 8.  Triple negative breast cancers: clinical and prognostic implications.

Authors:  S J Dawson; E Provenzano; C Caldas
Journal:  Eur J Cancer       Date:  2009-09       Impact factor: 9.162

9.  Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.

Authors:  Christopher I Li; Kathleen E Malone; Janet R Daling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-07       Impact factor: 4.254

Review 10.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

View more
  2 in total

1.  Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality.

Authors:  Mya L Roberson; Hazel B Nichols; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Whitney R Robinson
Journal:  Breast Cancer Res Treat       Date:  2022-03-14       Impact factor: 4.624

2.  Validity of breast cancer surgery treatment information in a state-based cancer registry.

Authors:  Mya L Roberson; Hazel B Nichols; Stephanie B Wheeler; Katherine E Reeder-Hayes; Andrew F Olshan; Christopher D Baggett; Whitney R Robinson
Journal:  Cancer Causes Control       Date:  2021-11-16       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.